Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Income-Before-Tax" stands at 21.82 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.
Merck & Company Inc's third quarter result of 6.74 Billion USD for the item "Income Before Tax" represents an increase of 34.93 percent compared to it's second quarter result.
Also, Merck & Company Inc's third quarter result of 6.74 Billion USD for the item "Income Before Tax" represents an increase of 64.91 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Merck & Company Inc's third quarter result of 21.82 Billion USD for the item "Income Before Tax" represents an increase of 13.86 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 59.02 percent compared to the value the year prior.
The 1 year change in percent is 59.02.
The 3 year change in percent is 29.55.
The 5 year change in percent is 80.66.
The 10 year change in percent is 33.06.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Income Before Tax | 905,699,262,464.00 |
![]() | Johnson & Johnson - Income Before Tax | 486,508,953,600.00 |
![]() | AbbVie Inc - Income Before Tax | 399,570,305,024.00 |
![]() | Roche Holding AG - Income Before Tax | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Income Before Tax | 280,205,508,085.11 |